RRC ID 82135
著者 Chow T, Humble W, Lucarelli E, Onofrillo C, Choong PF, Di Bella C, Duchi S.
タイトル Feasibility and barriers to rapid establishment of patient-derived primary osteosarcoma cell lines in clinical management.
ジャーナル iScience
Abstract Osteosarcoma is a highly aggressive primary bone tumor that has seen little improvement in survival rates in the past three decades. Preclinical studies are conducted on a small pool of commercial cell lines which may not fully reflect the genetic heterogeneity of this complex cancer, potentially hindering translatability of in vitro results. Developing a single-site laboratory protocol to rapidly establish patient-derived primary cancer cell lines (PCCL) within a clinically actionable time frame of a few weeks will have significant scientific and clinical ramifications. These PCCL can widen the pool of available cell lines for study while patient-specific data could derive therapeutic correlation. This endeavor is exceedingly challenging considering the proposed time constraints. By proposing key definitions and a clear theoretical framework, this evaluation of osteosarcoma cell line establishment methodology over the past three decades assesses feasibility by identifying barriers and suggesting solutions, thereby facilitating systematic experimentation and optimization.
巻・号 27(9)
ページ 110251
公開日 2024-9-20
DOI 10.1016/j.isci.2024.110251
PII S2589-0042(24)01476-7
PMID 39286504
PMC PMC11403063
IF 4.447
オルトメトリクス指標
オルトメトリクス指標項目
最多言及媒体 X(Twitter)
各媒体での言及数の合計 3
過去6か月間でのオルトメトリクス指標の変動値 0.0
リソース情報
ヒト・動物細胞 NOS-1(RCB1032) NOS-2(RCB1033) NOS-10(RCB2348)